
Ep90: James Sabry on Partnering Amid Scientific Abundance
The Long Run with Luke Timmerman
00:00
The Future of the Industry
I worry that people will start to generate near term benefit. And in theb, some of the bitet company's cases, near term financial benefit potentially at the expense of long term technological benefit. We have to keep our eye fully on the long term prized of truly developing an innovative medicine that really helps patients. Anything less than that is a slight waste of time, in my mind. Ifithink wat a forty year time tem on. It very optimistic. I'm so i'm not worried about the people. What i guess, by the way, is more vanerton,. The longer your time framed, the more timistic i become.
Transcript
Play full episode